Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 490.00K | $ 714.00K | $ 402.00K | $ 752.00K | $ 3.04M |
Total Assets | $ 36.23M | $ 32.20M | $ 40.41M | $ 40.71M | $ 40.95M |
Total Debt | $ 14.25M | $ 10.60M | $ 9.62M | $ 9.88M | $ 10.05M |
Net Debt | $ 13.76M | $ 9.88M | $ 9.22M | $ 9.13M | $ 7.01M |
Total Liabilities | $ 24.27M | $ 19.98M | $ 19.39M | $ 19.46M | $ 19.66M |
Stockholders Equity | $ 11.95M | $ 12.23M | $ 20.65M | $ 20.89M | $ 19.84M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |